Anant Agrawal

Company: Remix Therapeutics

Job title: Director, RNA Platform & Target Enablement

Seminars:

Panel Discussion – Revolutionizing RNA Assays to Characterize the Mechanism of Action for Advancing RNA Targeted Drug Development 11:00 am

Comparing different assay and screening approaches which the field is currently using to better understand the mechanism of action How to optimize current assays to better understand the mechanism of action? How to utilize phenotypic methods to delve into the underlying mechanism?Read more

day: Conference Day Two